Few studies identified that CTCF mutation was a prognostic factor for BC, even though the ability of CTCF of binding to the promoter/insulator sites of cell proliferation‐related genes could be influenced by CTCF gene mutation, and one isoform of CTCF protein (130 kDa) was identified as a BC biomarker [40]. Here, CTCF is linked to breast cancer.